Showing results (1-10 of 445) with videos related to
Sort By:
Pageof 45
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.Anticancer Research|June 12, 1999
Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastineN Meyer, S Duensing, G Anastassiou, et al.Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Dose distribution of low-dose subcutaneous recombinant interleukin-2 affects the secondary release of interferon-gamma in vivoM Meffert, S Duensing, J AtzpodienCancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinomaJ Buer, M Probst, S Duensing, et al.Anticancer Research|September 1, 1995
Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patientsS Duensing, J Grosse, J AtzpodienOncology|March 1, 1996
Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinomaG Anastassiou, S Duensing, G Steinhoff, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Loss of VLA-3 (CD49c/CD29) expression in two multidrug resistant Burkitt's lymphoma cell linesS Duensing, A Duensing, J Grosse, et al.British Journal of Cancer|July 14, 1998
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanomaA Franzke, M Probst-Kepper, J Buer, et al.British Journal of Cancer|January 1, 1997
Elevated serum levels of S100 and survival in metastatic malignant melanomaJ Buer, M Probst, A Franzke, et al.Pageof 45